がん診断における人工知能の世界市場規模調査＆予測、コンポーネント別、がんタイプ別、エンドユーザー別、地域別分析、2023-2030年

がん診断における人工知能の世界市場は、2022年に約1億3,780万米ドルと評価され、予測期間2023年から2030年にかけて26.3％以上の健全な成長率で成長すると予測されています。

がん診断における人工知能とは、AIアルゴリズムを応用してユーザーの医療データを分析し、がんを検出して早期治療に役立てることを指します。がん診断における人工知能市場は、医療費の増加、病気の早期発見に対する人気の高まり、医療専門家の不足といった要因から拡大しています。しかし、この技術を使用する人々のデータ保護に関する懸念や、AIのアルゴリズムにおけるデータの不整合や欠陥が、市場の成長を低下させる傾向にあります。

医療費の増加は、がん診断における人工知能市場を牽引する要因です。健康問題2023によると、医療費は2022年から31年にかけて5.4％成長し、その期間の終わりまでに経済の約20％を占めると予測されています。疾病の早期発見は、その疾病の容易かつ迅速な治療につながり、さらに医療専門家の不足は、ヘルスケア分野でのAI市場の成長につながった。Cancer Research UK 2023によると、2040年までに世界で毎年2,800万人の新たながん患者が発生すると推定されているため、がん患者の増加がこの市場の成長機会となっています。Statista 2023によると、2022年にはデジタルトランスフォーメーションへの支出は1兆6,000億米ドルに達すると推定されています。2026年には、世界のデジタルトランスフォーメーションへの支出は3兆4,000億米ドルに達すると予測されています。

がん診断における人工知能の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、ヘルスケア分野での技術進歩の上昇、この地域における市場プレイヤーの存在、デジタル変革の進展と相まってがん患者が増加していることから、2022年に市場を独占しました。アジア太平洋地域は、ヘルスケア分野における政府の取り組みやAIベースのがん診断技術の人気の高まりなどの要因により、予測期間中に大きく成長することが期待されています。

本調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 がん診断における人工知能の世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 がん診断における人工知能の世界市場力学

• がん診断における人工知能市場の影響分析（2020-2030年）
  • 市場促進要因
    • ヘルスケア支出の増加
    • 疾病の早期発見に対する人気の高まり
  • 市場の課題
    • データ保護に関する懸念
    • データの不整合とAIアルゴリズムの欠陥
  • 市場機会
    • 技術進歩の高まり
    • がん患者の増加

第4章 がん診断における人工知能の世界市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 がん診断における人工知能の世界市場：コンポーネント別

• 市場スナップショット
• がん診断における人工知能の世界市場：コンポーネント別、実績 - ポテンシャル分析
• がん診断における人工知能の世界市場：コンポーネント別推定・予測、2020～2030年
• がん診断における人工知能市場、サブセグメント分析
  • ソフトウェアソリューション
  • ハードウェア
  • サービス

第6章 がん診断における人工知能の世界市場：がんタイプ別

• 市場スナップショット
• がん診断における人工知能の世界市場：がんタイプ別、実績 - ポテンシャル分析
• がん診断における人工知能の世界市場：がんタイプ別推定・予測、2020～2030年
• がん診断における人工知能市場、サブセグメント分析
  • 乳がん
  • 肺がん
  • 前立腺がん
  • 大腸がん
  • 脳腫瘍
  • その他

第7章 がん診断における人工知能の世界市場：エンドユーザー別

• 市場スナップショット
• がん診断における人工知能の世界市場：エンドユーザー別、実績 - ポテンシャル分析
• がん診断における人工知能の世界市場：エンドユーザー別推定・予測、2020～2030年
• がん診断における人工知能市場、サブセグメント分析
  • 病院
  • 外科センターおよび医療機関
  • その他

第8章 がん診断における人工知能の世界市場：地域別分析

• 主要国
• 主な新興国
• がん診断における人工知能市場、地域別市場スナップショット
• 北米
  • 米国
  • カナダ
• 欧州のがん診断における人工知能市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋のがん診断における人工知能市場のスナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカのがん診断における人工知能市場のスナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第9章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Medial EarlySign Ltd.
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 最近の動向
  • Cancer Center.ai
  • Microsoft Corporation
  • Flatiron Health
  • PATHAI, INC.
  • Google Deep Mind
  • Tempus Labs, Inc.
  • Oncora Medical
  • Whiterabbit.ai
  • Ibex Medical Analytics

第10章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Artificial Intelligence in Cancer Diagnostics Market, report scope
• TABLE 2. Global Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by Region 2020-2030 (USD Million)
• TABLE 3. Global Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by Component 2020-2030 (USD Million)
• TABLE 4. Global Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by Cancer Type 2020-2030 (USD Million)
• TABLE 5. Global Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by End User 2020-2030 (USD Million)
• TABLE 6. Global Artificial Intelligence in Cancer Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 7. Global Artificial Intelligence in Cancer Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 8. Global Artificial Intelligence in Cancer Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 9. Global Artificial Intelligence in Cancer Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 10. Global Artificial Intelligence in Cancer Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 11. Global Artificial Intelligence in Cancer Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 12. Global Artificial Intelligence in Cancer Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 13. Global Artificial Intelligence in Cancer Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 14. Global Artificial Intelligence in Cancer Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 15. Global Artificial Intelligence in Cancer Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 16. U.S. Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 17. U.S. Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 18. U.S. Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 19. Canada Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 20. Canada Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 21. Canada Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 22. UK Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 23. UK Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 24. UK Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 25. Germany Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 26. Germany Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 27. Germany Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 28. France Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 29. France Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 30. France Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 31. Italy Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 32. Italy Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 33. Italy Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 34. Spain Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 35. Spain Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 36. Spain Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 37. RoE Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 38. RoE Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 39. RoE Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 40. China Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 41. China Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 42. China Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 43. India Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 44. India Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 45. India Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 46. Japan Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 47. Japan Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 48. Japan Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 49. South Korea Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 50. South Korea Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 51. South Korea Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 52. Australia Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 53. Australia Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 54. Australia Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 55. RoAPAC Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 56. RoAPAC Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 57. RoAPAC Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 58. Brazil Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 59. Brazil Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 60. Brazil Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 61. Mexico Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 62. Mexico Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 63. Mexico Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 64. RoLA Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 65. RoLA Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 66. RoLA Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 67. Saudi Arabia Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 68. South Africa Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 69. RoMEA Artificial Intelligence in Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 70. List of secondary sources, used in the study of global Artificial Intelligence in Cancer Diagnostics Market
• TABLE 71. List of primary sources, used in the study of global Artificial Intelligence in Cancer Diagnostics Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1. Global Artificial Intelligence in Cancer Diagnostics Market, research methodology
• FIG 2. Global Artificial Intelligence in Cancer Diagnostics Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Artificial Intelligence in Cancer Diagnostics Market, key trends 2022
• FIG 5. Global Artificial Intelligence in Cancer Diagnostics Market, growth prospects 2023-2030
• FIG 6. Global Artificial Intelligence in Cancer Diagnostics Market, porters 5 force model
• FIG 7. Global Artificial Intelligence in Cancer Diagnostics Market, pest analysis
• FIG 8. Global Artificial Intelligence in Cancer Diagnostics Market, value chain analysis
• FIG 9. Global Artificial Intelligence in Cancer Diagnostics Market by segment, 2020 & 2030 (USD Million)
• FIG 10. Global Artificial Intelligence in Cancer Diagnostics Market by segment, 2020 & 2030 (USD Million)
• FIG 11. Global Artificial Intelligence in Cancer Diagnostics Market by segment, 2020 & 2030 (USD Million)
• FIG 12. Global Artificial Intelligence in Cancer Diagnostics Market by segment, 2020 & 2030 (USD Million)
• FIG 13. Global Artificial Intelligence in Cancer Diagnostics Market by segment, 2020 & 2030 (USD Million)
• FIG 14. Global Artificial Intelligence in Cancer Diagnostics Market, regional snapshot 2020 & 2030
• FIG 15. North America Artificial Intelligence in Cancer Diagnostics Market 2020 & 2030 (USD Million)
• FIG 16. Europe Artificial Intelligence in Cancer Diagnostics Market 2020 & 2030 (USD Million)
• FIG 17. Asia pacific Artificial Intelligence in Cancer Diagnostics Market 2020 & 2030 (USD Million)
• FIG 18. Latin America Artificial Intelligence in Cancer Diagnostics Market 2020 & 2030 (USD Million)
• FIG 19. Middle East & Africa Artificial Intelligence in Cancer Diagnostics Market 2020 & 2030 (USD Million)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Artificial Intelligence in Cancer Diagnostics Market is valued at approximately USD 137.8 million in 2022 and is anticipated to grow with a healthy growth rate of more than 26.3% over the forecast period 2023-2030. Artificial Intelligence in Cancer Diagnostics refers to applying AI algorithms to analyze the medical data of users to detect cancer and help in treating it at an early stage. The Artificial Intelligence in Cancer Diagnostics Market is expanding because of factors such as a rise in healthcare expenditure, an increase in popularity for early detection of diseases and a shortage of healthcare professionals. However, data protection concerns of people using the technology and data inconsistency and flaws in the algorithm of AI tend to lower the market growth.

The rise in health care expenditure is a factor driving Artificial Intelligence In Cancer Diagnostics Market . According to health affairs 2023, health expenditures are predicted to grow 5.4%, in 2022-31 and to account for roughly 20% of the economy by the end of that period. The increase in popularity for early detection of diseases is another driving this market as people are now more concerned about their health and they want to detect every disease at an early stage as early detection of disease leads to easy and fast treatment of that disease moreover shortage of health care professionals has led the AI market to grow in the health care sector. An increase in cancer cases is an opportunity for this market to grow as according to Cancer Research UK 2023 it is estimated that there be 28 million new cancer cases globally each year by 2040. Another opportunity for this market to expand is a rise in technological advancement according to Statista 2023, in 2022, spending on digital transformation is estimated to reach USD 1.6 trillion. By 2026, global digital transformation spending is forecast to reach USD 3.4 trillion.

The key regions considered for the Global Artificial Intelligence in Cancer Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rise in the advancement of technology in the healthcare sector, the presence of market players in this region and growing cancer cases coupled with growing digital transformation has led to the growth of the market in this region. Asia Pacific is expected to grow significantly over the forecast period, owing to factors such as government initiatives in the healthcare sector and the rise in popularity of AI-based cancer diagnostic technologies.

Major market player included in this report are:

• Medial EarlySign Ltd.
• Cancer Center.ai
• Microsoft Corporation
• Flatiron Health
• PATHAI, INC.
• Google Deep Mind
• Tempus Labs, Inc.
• Oncora Medical
• Whiterabbit.ai
• Ibex Medical Analytics

Recent Developments in the Market:

• In May 2023, EarlySign, a cutting-edge business creating AI-based clinical predictive analytics announced a collaboration with Roche, it enable Roche Diagnostics to include EarlySign ColonFlag in its navify algorithm Suite. ColonFlag signifies a continuation of growth for the navify portfolio of digital solutions and expands on the collaborations between EarlySign and Roche to promote early diagnosis of stomach and lung cancer.
• In June 2023, Tempus launched the Standalone RNA Sequencing Test, xR. A Tempus xR is made for solid tumors and is a transcriptome panel. That detects aberrant splicing for MET Exon 14 and EGFRvIII as well as clinically significant combination of 100 targeted genes.

Global Artificial Intelligence in Cancer Diagnostics Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Component, Cancer, End User Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Component:

• Software Solutions
• Hardware
• Services

By Cancer Type:

• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Brain Tumor
• Others

By End User:

• Hospital
• Surgical Centers and Medical Institutes
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1. Artificial Intelligence in Cancer Diagnostics Market, by Region, 2020-2030 (USD Million)
  • 1.2.2. Artificial Intelligence in Cancer Diagnostics Market, by Component, 2020-2030 (USD Million)
  • 1.2.3. Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2030 (USD Million)
  • 1.2.4. Artificial Intelligence in Cancer Diagnostics Market, by End User, 2020-2030 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Artificial Intelligence in Cancer Diagnostics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Artificial Intelligence in Cancer Diagnostics Market Dynamics

• 3.1. Artificial Intelligence in Cancer Diagnostics Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rise in healthcare expenditure
    • 3.1.1.2. Increase in popularity for early detection of diseases
  • 3.1.2. Market Challenges
    • 3.1.2.1. Data protection concerns
    • 3.1.2.2. Data inconsistency and flaws in algorithm of AI
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rise in technological advancement
    • 3.1.3.2. Increase in cancer cases

Chapter 4. Global Artificial Intelligence in Cancer Diagnostics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Artificial Intelligence in Cancer Diagnostics Market, by Component

• 5.1. Market Snapshot
• 5.2. Global Artificial Intelligence in Cancer Diagnostics Market by Component, Performance - Potential Analysis
• 5.3. Global Artificial Intelligence in Cancer Diagnostics Market Estimates & Forecasts by Component 2020-2030 (USD Million)
• 5.4. Artificial Intelligence in Cancer Diagnostics Market, Sub Segment Analysis
  • 5.4.1. Software Solutions
  • 5.4.2. Hardware
  • 5.4.3. Services

Chapter 6. Global Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type

• 6.1. Market Snapshot
• 6.2. Global Artificial Intelligence in Cancer Diagnostics Market by Cancer Type, Performance - Potential Analysis
• 6.3. Global Artificial Intelligence in Cancer Diagnostics Market Estimates & Forecasts by Cancer Type 2020-2030 (USD Million)
• 6.4. Artificial Intelligence in Cancer Diagnostics Market, Sub Segment Analysis
  • 6.4.1. Breast Cancer
  • 6.4.2. Lung Cancer
  • 6.4.3. Prostate Cancer
  • 6.4.4. Colorectal Cancer
  • 6.4.5. Brain Tumor
  • 6.4.6. Others

Chapter 7. Global Artificial Intelligence in Cancer Diagnostics Market, by End User

• 7.1. Market Snapshot
• 7.2. Global Artificial Intelligence in Cancer Diagnostics Market by End User, Performance - Potential Analysis
• 7.3. Global Artificial Intelligence in Cancer Diagnostics Market Estimates & Forecasts by End User 2020-2030 (USD Million)
• 7.4. Artificial Intelligence in Cancer Diagnostics Market, Sub Segment Analysis
  • 7.4.1. Hospital
  • 7.4.2. Surgical Centers and Medical Institutes
  • 7.4.3. Others

Chapter 8. Global Artificial Intelligence in Cancer Diagnostics Market, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Artificial Intelligence in Cancer Diagnostics Market, Regional Market Snapshot
• 8.4. North America Artificial Intelligence in Cancer Diagnostics Market
  • 8.4.1. U.S. Artificial Intelligence in Cancer Diagnostics Market
    • 8.4.1.1. Component breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Cancer Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Artificial Intelligence in Cancer Diagnostics Market
• 8.5. Europe Artificial Intelligence in Cancer Diagnostics Market Snapshot
  • 8.5.1. U.K. Artificial Intelligence in Cancer Diagnostics Market
  • 8.5.2. Germany Artificial Intelligence in Cancer Diagnostics Market
  • 8.5.3. France Artificial Intelligence in Cancer Diagnostics Market
  • 8.5.4. Spain Artificial Intelligence in Cancer Diagnostics Market
  • 8.5.5. Italy Artificial Intelligence in Cancer Diagnostics Market
  • 8.5.6. Rest of Europe Artificial Intelligence in Cancer Diagnostics Market
• 8.6. Asia-Pacific Artificial Intelligence in Cancer Diagnostics Market Snapshot
  • 8.6.1. China Artificial Intelligence in Cancer Diagnostics Market
  • 8.6.2. India Artificial Intelligence in Cancer Diagnostics Market
  • 8.6.3. Japan Artificial Intelligence in Cancer Diagnostics Market
  • 8.6.4. Australia Artificial Intelligence in Cancer Diagnostics Market
  • 8.6.5. South Korea Artificial Intelligence in Cancer Diagnostics Market
  • 8.6.6. Rest of Asia Pacific Artificial Intelligence in Cancer Diagnostics Market
• 8.7. Latin America Artificial Intelligence in Cancer Diagnostics Market Snapshot
  • 8.7.1. Brazil Artificial Intelligence in Cancer Diagnostics Market
  • 8.7.2. Mexico Artificial Intelligence in Cancer Diagnostics Market
• 8.8. Middle East & Africa Artificial Intelligence in Cancer Diagnostics Market
  • 8.8.1. Saudi Arabia Artificial Intelligence in Cancer Diagnostics Market
  • 8.8.2. South Africa Artificial Intelligence in Cancer Diagnostics Market
  • 8.8.3. Rest of Middle East & Africa Artificial Intelligence in Cancer Diagnostics Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Medial EarlySign Ltd.
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. Cancer Center.ai
  • 9.3.3. Microsoft Corporation
  • 9.3.4. Flatiron Health
  • 9.3.5. PATHAI, INC.
  • 9.3.6. Google Deep Mind
  • 9.3.7. Tempus Labs, Inc.
  • 9.3.8. Oncora Medical
  • 9.3.9. Whiterabbit.ai
  • 9.3.10. Ibex Medical Analytics

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption